Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Stocks News & Analysis
stocks
Wildly overvalued ASX stock is skating on thin ice
stocks
Uber flexes its network effect and delivers strong result
stocks
Ask the analyst: Are Qantas shares a value trap?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,102.00 | 9.10 | -0.10% |
CAC 40 | 7,709.32 | 74.29 | 0.97% |
DAX 40 | 24,192.50 | 268.14 | 1.12% |
Dow JONES (US) | 43,968.64 | 224.48 | -0.51% |
FTSE 100 | 9,100.77 | 63.54 | -0.69% |
HKSE | 25,081.63 | 171.00 | 0.69% |
NASDAQ | 21,242.70 | 73.27 | 0.35% |
Nikkei 225 | 41,059.15 | 264.29 | 0.65% |
NZX 50 Index | 12,876.02 | 11.08 | -0.09% |
S&P 500 | 6,340.00 | 5.06 | -0.08% |
S&P/ASX 200 | 8,831.40 | 12.30 | -0.14% |
SSE Composite Index | 3,639.67 | 5.67 | 0.16% |